Voices From the Field

Feature Img

U.S. Ambassador to Tanzania Visits MHRP site in Mbeya More >>

Ugandan youth create murals to help promote HIV prevention More >>

MHRP Researcher Receives HIV Prevention Research Advocacy Fellowship More >>


HIV Vaccine Study First to Show Some Effectiveness in Preventing HIV

An Army-sponsored phase III clinical trial (RV144) involving more than 16,000 adult volunteers in Thailand has demonstrated that an investigational HIV vaccine regimen was safe and modestly effective in preventing HIV infection. More >>

RV144: Submit a Research Concept


MHRP's International Network

News

Paper published on Phase I/II Study of a Vaccine Candidate in East Africa

MHRP researchers describe the safety and immunogenicity of a multiclade DNA vaccine prime with a muticlade recombinant adenovirus serotype 5 (rAd5) boost More >>

RV144 Vaccine Regimen Tops ‘Best of’ Lists in 2009

The trial was rated number two on TIME magazine’s Top 10 Medical Breakthroughs list for 2009 among others More >>

New Insight into Selective Binding Properties of Infectious HIV

Human Erythrocytes Selectively Bind and Enrich Infectious HIV-1 Virions More >>

Phase Ib Ebola/Marburg Vaccine Clinical Trial Begins

First volunteers are vaccinated in Uganda More >>

AIDS Vaccine Conference 2009

MHRP scientists present data on RV144 and a new DNA/MVA HIV vaccine candidate More >>

Tanzania President Dedicates Mobile Diagnostic Lab

May Help Combat TB and HIV in Tanzania More >>

Exchange

Exchange Newsletter

MHRP PEPFAR Exchange, Vol. IV More >>

"A Little Bit of Love"
HIV awareness music video
Video 160
video | press release | lyrics

Collaborating partners

IDCRP